Tumor and organ uptake of Cu-64 labeled amatuximab, an anti-mesothelin antibody, in a nude mouse model bearing a shed antigen tumor by mathematical model simulation

被引：0

作者：

Lee, Jae-Ho ^{[1
]}

机构：

[1] NIH, NMD, RIS, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2017年 / 254卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

273

引用

页数：2

共 30 条

[21] "Catch-and-Release" Anti-Carcinoembryonic Antigen Monoclonal Antibody Leads to Greater Plasma and Tumor Exposure in a Mouse Model of Colorectal Cancer
Engler, Frank A.
Polli, Joseph Ryan
Li, Tommy
An, Bo
Otteneder, Michael
Qu, Jun
Balthasar, Joseph P.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018, 366 (01): : 205 - 219
[22] PET imaging of cell surface GRP78 expression in BxPC-3 tumor model using 64Cu-labeled MAb159 antibody
Liu, Shuanglong
Li, Dan
Liu, Ren
Gill, Parkash
Shan, Hong
Conti, Peter
Li, Zibo
JOURNAL OF NUCLEAR MEDICINE, 2014, 55
[23] MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue
Rogers, BE
Bigott, HM
McCarthy, DW
Della Manna, D
Kim, J
Sharp, TL
Welch, MJ
BIOCONJUGATE CHEMISTRY, 2003, 14 (04) : 756 - 763
[24] Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model:: Evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy
Lewis, JS
Lewis, MR
Srinivasan, A
Schmidt, MA
Wang, J
Anderson, CJ
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (08) : 1341 - 1347
[25] 89Zr-labeled anti-PD-1 antibody for in vivo monitoring of infiltrating PD-1+ T lymphocytes in a pancreatic tumor mouse model
Liu, Liang
Geller, Anne
Yan, Jun
Guo, Haixun
JOURNAL OF NUCLEAR MEDICINE, 2020, 61
[26] Anti-tumor effect of an anti-human Mullerian Inhibiting Substance type II receptor antibody in a nude mouse model for granulosa cell tumors: a new targeted therapy for ovarian cancer
Kersual, N.
Garambois, V.
Salhi, I.
Larbouret, C.
Bibeau, F.
Mollevi, C.
Chardes, T.
Pelegrin, A.
Teulon, I.
EJC SUPPLEMENTS, 2008, 6 (12): : 163 - 163
[27] Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7-14)NH2], in a prostate tumor xenografted mouse model
Lane, Stephanie R.
Nanda, Prasanta
Rold, Tammy L.
Sieckman, Gary L.
Figueroa, Said D.
Hoffman, Timothy J.
Jurisson, Silvia S.
Smith, Charles J.
NUCLEAR MEDICINE AND BIOLOGY, 2010, 37 (07) : 751 - 761
[28] Tumor-specific accumulation of I-125-labeled mouse-human chimeric anti-CEA antibody in a xenografted human cancer model demonstrated by whole-body autoradiography and immunostaining
Haruno, M
Kuroki, M
Matsunaga, K
Takata, J
Karube, Y
Senba, T
Murakami, M
Arakawa, F
Kuwahara, M
Ozaki, H
Matsuoka, Y
Okazaki, M
Kanda, H
NUCLEAR MEDICINE AND BIOLOGY, 1996, 23 (06): : 821 - 826
[29] Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγnull mouse model
Ito, Asahi
Ishida, Takashi
Yano, Hiroki
Inagaki, Atsushi
Suzuki, Susumu
Sato, Fumihiko
Takino, Hisashi
Mori, Fumiko
Ri, Masaki
Kusumoto, Shigeru
Komatsu, Hirokazu
Iida, Shinsuke
Inagaki, Hiroshi
Ueda, Ryuzo
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (08) : 1195 - 1206
[30] Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγnull mouse model
Asahi Ito
Takashi Ishida
Hiroki Yano
Atsushi Inagaki
Susumu Suzuki
Fumihiko Sato
Hisashi Takino
Fumiko Mori
Masaki Ri
Shigeru Kusumoto
Hirokazu Komatsu
Shinsuke Iida
Hiroshi Inagaki
Ryuzo Ueda
Cancer Immunology, Immunotherapy, 2009, 58 : 1195 - 1206

← 1 2 3 →